Porcine reproductive and respiratory syndrome continues to be the costliest disease affecting swine operations today, with estimates coming in over $500 million in annual productivity losses. Adding to the difficulty of battling the disease, new strains continue to evolve.

With this in mind, Elanco Animal Health and National Hog Farmer are teaming up to bring you the webinar “Introducing Prevacent PRRS, a new PRRS respiratory vaccine” at 1 p.m. (Central) Nov. 7.

Elanco technical consultant Mark Hammer, DVM, invites you to learn about the prevalence of Lineage 1 porcine reproductive and respiratory syndrome strains affecting today’s hog operations and to discover Prevacent PRRS, a new PRRS vaccine from Elanco that helps swine producers meet the porcine reproductive and respiratory syndrome challenge.

• PRRS is a costly disease that affects swine operations today

º PRRS strains change and adapt over the years. Previously, vaccine strains from Lineages 5 and 8 were most prevalent, until the emergence of Lineage 1 strains as the most prevalent in the mid-2000s
º According to a recent summary presented at the 2018 Allen D. Leman Conference, most of the circulating PRRS strains in the United States belong to Lineage 1

 • Prevacent PRRS is a USDA-licensed, modified-live respiratory vaccine that has been shown to be effective in the reduction of PRRS, respiratory form, in piglets 2 weeks of age or older

º Demonstrated 26-week duration of immunity against respiratory disease in piglets
º Convenient 1 milliliter intramuscular dose
º Contains a more contemporary field strain than other modified-live PRRS vaccines

National Hog Farmer Senior Staff Writer Kevin Schulz will moderate the webinar. Find out what makes Prevacent PRRS different from other respiratory vaccines. Click here to register.